Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Vicki Keedy

4 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCMD1672

    04/07/2017

    A Phase II Study of the PARP Inhibitor Olaparib (AZD2281) Alone and in Combination with AZD1775, AZD5363, or AZD2014 in Advanced Solid Tumors - OLAPCO (OLAParib COmbinations)

    Treatment

    VICCPHI15149

    02/20/2017

    A Phase I Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK2820151 in Subjects with Advanced or Recurrent Solid Tumors

    Treatment

    VICCSAR1483

    02/26/2015

    SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients with Refractory Liposarcoma, Osteogenic Sarcoma, and Ewing/Ewing-like Sarcomas

    Treatment

    VICCPHI1435

    07/31/2014

    First-in-Human Dose-Escalation Study of TEW-7197 Monotherapy in Subjects with Advanced Stage Solid Tumors


    Print this page for your doctor